Connect with us

Life Sciences

AI Risk And The White House

The Biden Administration Is Trying to Establish Some Limits Healthcare providers and payers have joined 15 other prominent AI businesses in pledging to…

Published

on

This article was originally published by AITHORITY

The Biden Administration Is Trying to Establish Some Limits

Healthcare providers and payers have joined 15 other prominent AI businesses in pledging to properly build AI models. These organizations include OpenAI, Google, and OpenAI partner Microsoft. As artificial intelligence continues to grow in popularity and capacity with no regulation, the Biden administration is trying to establish some limits on it. According to a White House official, twenty-eight healthcare businesses, including CVS Health, have agreed to accept a set of voluntary obligations that U.S. President Joe Biden has proposed to keep AI development safe.

Read: Top 10 Benefits Of AI In The Real Estate Industry

White House Issues Executive Order to “Seize the Promise and Manage the Risks” of AI

Without enough supervision, the official said, AI diagnoses might be skewed due to gender or ethnicity, particularly if the data used to train the AI does not reflect the community it is meant to help. According to the administration’s plan, businesses should notify consumers when they come across information that is mostly created by AI without human review or editing, and they should also keep an eye out for any damage that apps might do.

Read 10 AI In Manufacturing Trends To Look Out For In 2024

Companies who join the pledges promise to responsibly employ AI in their product development processes. This includes creating solutions that help patients in many ways, such as reducing clinician fatigue, increasing access to care, improving outcomes through care coordination, and advancing health justice.

Addressing Bias

The Executive Order (EO) mandates that government agencies work toward eliminating discrimination and algorithmic bias in AI systems. It asks for the creation of guidelines and best practices to reduce algorithmic bias, checks that AI systems adhere to civil rights laws, evaluates them to find unfair effects on protected groups, and gives humans a chance to review AI’s bad decisions. It goes on to say that the DOJ should work together on civil rights enforcement cases including AI bias.

Notably, the EO urges the heads of the Federal Housing Finance Agency and the Consumer Financial Protection Bureau to evaluate the possibility of using their powers to employ suitable methodology, including artificial intelligence technologies, to guarantee adherence to federal laws. This involves checking their automated collateral evaluation and valuation systems for prejudice and inequalities that can impact protected classes, as well as their underwriting models.

Read: 4 Common Myths Related To Women In The Workplace

Safety Testing

The findings of safety testing must be shared with the government before any artificial intelligence system that might endanger U.S. national security, the economy, public health, or safety can be released to the public, according to an executive order issued by Biden on October 30, 2023. Oscar, Curai, Devoted Health, Duke Health, Emory Healthcare, and WellSpan Health are among the providers who have signed the agreements, according to the White House official.

[To share your insights with us, please write to sghosh@martechseries.com]

The post AI Risk And The White House appeared first on AiThority.



artificial intelligence

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending